The ratios are based on vaccination % prevailing 30 days prior to each data point, so that it reflects the true effect of vaccination.
It must also be kept in mind that the vaccinated segment by default are older, more likely to fall sick and have serious outcomes.
2/
This implies that the ratios are an underestimate of the true protection offered by vaccines.
In other words, we are not comparing groups of equal health status when we do a ratio of the unvaccinated and vaccinated.
The true protection will be larger.
3/
We must also factor in the “parallel immunisation process” that occurs in the unvaccinated group - on account of their picking up immunity due to asymptomatic and symptomatic natural infections.
This will eventually be reflected in their event rates in subsequent months.
4/
A similar trend was observed in Oregon, I had tweeted earlier on the event rates, and the ratio remained consistently at around 2.8.
Obviously real-world effectiveness studies have their limitations, but these are state-reported data and probably the most reliable.
5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The presence of long lived memory B cells had previously been established in several papers, see my tweets. This paper focuses on memory T cells in response to 2 doses of mRNA vaccine.
I will discuss some basic immunology first, to help understand the context of this paper.
2/
Following the innate response, the adaptive immulogical response to a virus infection is basically two pronged.
The two arms are T cells and B cells.
B cells make antibodies which work like security guards OUTSIDE our gate, preventing the thief from entering the premises.
3/
The most powerful graph that I have seen of the pandemic.
This calls for a rethink of vaccination strategy.
Note the sharp demarcation around age 40-45.
Vaccination of this 40+ segment needs priority.
Below that age, it could even be made optional. Here’s why👇
(Thread)
Although vaccines were launched with a hope of stopping transmission and further waves, we have seen that high % vaccination coverage does not stop subsequent waves. This is because they are ineffective in providing mucosal immunity; virus is silently spreading in communities.
2/
At the same time, we have found that vaccines are not 100% benign products as is often suggested by certain academics.
They have failed to acknowledge the small but significant number of serious and fatal outcomes is that occurred - particularly among younger individuals.
3/
The study looked at vaccinated and and vaccinated people in Sweden and looked at the event rates up to 9 months.
They calculated vaccine effectiveness at regular intervals until past six months. The authors conclude erroneously that vaccine effectiveness drops to (zero).
2/
The traditional method of calculating effectiveness is to compare the outcomes in the vaccinated & vaccinated groups and see the percentage difference between the two.
Eg. If 10 events happen in the unvax group and only 1 event occurs in the vax group, effectiveness is 90%.
3/
First detailed description of immune response following breakthrough infections. This is a study on a subset of 35 people (infected vs uninfected) from the Provincetown Massachusetts outbreak, US.
At the same time, vaccinated individuals are less likely to be admitted to hospital, or die from COVID-19.
The reported death protection is likely to be an underestimation, because vaccination preferentially occurs among people who have more background illnesses.
2/
The question is why the rate of infection is higher among vaccinated people.
It is obvious by now that vaccines aren’t very good at stopping the virus from entering the nose or throat, particularly past the initial few weeks of high antibody titres.
3/